Legal Opinion
Intelligent Bio-Systems, Inc. v. Illumina Cambridge Ltd.
Court of Appeals for the Federal Circuit
Decided May 9, 2016No. 2015-1693PublishedCited by 112 opinions
1Opinion of the Court
O’MALLEY, Circuit Judge.
Illumina Cambridge Ltd. (“Illumina”) owns U.S. Patent No. 7,566,537 (“the '537 patent”), which is directed to a method of labeling nucleotides in a deoxyribonucleic acid (“DNA”) strand. Intelligent Bio-Systems, Inc. (“IBS”) filed a revised petition to the • Patent Trial and Appeal Board (“Board”) requesting inter partes review of claims 1-6 and 8 of the '537 patent on August 30, 2013. The Board instituted review of the challenged ' claims on the basis that they were invalid as obvious under 35 U.S.C. § 103 in view of certain prior art references. In its Final Written…
2Cases cited13 opinions
- Consolidated Edison Co. v. National Labor Relations BoardSupreme Court of the United States · 1938
- KSR International Co. v. Teleflex Inc.Supreme Court of the United States · 2007
- Stratoflex, Inc. v. Aeroquip CorporationCourt of Appeals for the Federal Circuit · 1983
- In Re Robert J. Gartside and Richard C. NortonCourt of Appeals for the Federal Circuit · 2000
- Wms Gaming Inc. v. International Game TechnologyCourt of Appeals for the Federal Circuit · 1999
8 more not listed; retrieve them via the Exa API.
3Cited by112 opinions
- Wasica Finance GmbH v. Continental Automotive Systems, Inc.Court of Appeals for the Federal Circuit · 2017
- In Re Magnum Oil Tools International, Ltd.Court of Appeals for the Federal Circuit · 2016
- Personal Web Technologies, LLC v. Apple, Inc.Court of Appeals for the Federal Circuit · 2017
- Osi Pharmaceuticals, LLC v. Apotex Inc.Court of Appeals for the Federal Circuit · 2019
- Henny Penny Corporation v. Frymaster LLCCourt of Appeals for the Federal Circuit · 2019
107 more not listed; retrieve them via the Exa API.